These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 31888685)

  • 1. Musashi2 contributes to the maintenance of CD44v6+ liver cancer stem cells via notch1 signaling pathway.
    Wang X; Wang R; Bai S; Xiong S; Li Y; Liu M; Zhao Z; Wang Y; Zhao Y; Chen W; Billiar TR; Cheng B
    J Exp Clin Cancer Res; 2019 Dec; 38(1):505. PubMed ID: 31888685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Musashi 2 contributes to the stemness and chemoresistance of liver cancer stem cells via LIN28A activation.
    Fang T; Lv H; Wu F; Wang C; Li T; Lv G; Tang L; Guo L; Tang S; Cao D; Wu M; Yang W; Wang H
    Cancer Lett; 2017 Jan; 384():50-59. PubMed ID: 27721018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FAM83D associates with high tumor recurrence after liver transplantation involving expansion of CD44+ carcinoma stem cells.
    Lin B; Chen T; Zhang Q; Lu X; Zheng Z; Ding J; Liu J; Yang Z; Geng L; Wu L; Zhou L; Zheng S
    Oncotarget; 2016 Nov; 7(47):77495-77507. PubMed ID: 27769048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells.
    Wang R; Sun Q; Wang P; Liu M; Xiong S; Luo J; Huang H; Du Q; Geller DA; Cheng B
    Oncotarget; 2016 Feb; 7(5):5754-68. PubMed ID: 26735577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A positive feedback loop between Periostin and TGFβ1 induces and maintains the stemness of hepatocellular carcinoma cells via AP-2α activation.
    Chen G; Wang Y; Zhao X; Xie XZ; Zhao JG; Deng T; Chen ZY; Chen HB; Tong YF; Yang Z; Ding XW; Guo PY; Yu HT; Wu LJ; Zhang SN; Zhu QD; Li JJ; Shan YF; Yu FX; Yu ZP; Xia JL
    J Exp Clin Cancer Res; 2021 Jun; 40(1):218. PubMed ID: 34193219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ZBP-89 negatively regulates self-renewal of liver cancer stem cells via suppression of Notch1 signaling pathway.
    Wang N; Li MY; Liu Y; Yu J; Ren J; Zheng Z; Wang S; Yang S; Yang SL; Liu LP; Hu BG; Chong CC; Merchant JL; Lai PB; Chen GG
    Cancer Lett; 2020 Mar; 472():70-80. PubMed ID: 31874246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Musashi2 predicts poor prognosis and invasion in hepatocellular carcinoma by driving epithelial-mesenchymal transition.
    He L; Zhou X; Qu C; Hu L; Tang Y; Zhang Q; Liang M; Hong J
    J Cell Mol Med; 2014 Jan; 18(1):49-58. PubMed ID: 24305552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-302a/d inhibits the self-renewal capability and cell cycle entry of liver cancer stem cells by targeting the E2F7/AKT axis.
    Ma YS; Lv ZW; Yu F; Chang ZY; Cong XL; Zhong XM; Lu GX; Zhu J; Fu D
    J Exp Clin Cancer Res; 2018 Oct; 37(1):252. PubMed ID: 30326936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
    Huang WC; Tung SL; Chen YL; Chen PM; Chu PY
    BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGF19/SOCE/NFATc2 signaling circuit facilitates the self-renewal of liver cancer stem cells.
    Wang J; Zhao H; Zheng L; Zhou Y; Wu L; Xu Y; Zhang X; Yan G; Sheng H; Xin R; Jiang L; Lei J; Zhang J; Chen Y; Peng J; Chen Q; Yang S; Yu K; Li D; Xie Q; Li Y
    Theranostics; 2021; 11(10):5045-5060. PubMed ID: 33754043
    [No Abstract]   [Full Text] [Related]  

  • 11. An essential role of RNF187 in Notch1 mediated metastasis of hepatocellular carcinoma.
    Zhang L; Chen J; Yong J; Qiao L; Xu L; Liu C
    J Exp Clin Cancer Res; 2019 Sep; 38(1):384. PubMed ID: 31477177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. iNOS promotes CD24
    Wang R; Li Y; Tsung A; Huang H; Du Q; Yang M; Deng M; Xiong S; Wang X; Zhang L; Geller DA; Cheng B; Billiar TR
    Proc Natl Acad Sci U S A; 2018 Oct; 115(43):E10127-E10136. PubMed ID: 30297396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.
    Toh TB; Lim JJ; Hooi L; Rashid MBMA; Chow EK
    J Hepatol; 2020 Jan; 72(1):104-118. PubMed ID: 31541681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific inhibition of Notch1 signaling suppresses properties of lung cancer stem cells.
    Cai H; Lu W; Zhang Y; Liu H; Wang Z; Shen Y
    J Cancer Res Ther; 2019; 15(7):1547-1552. PubMed ID: 31939436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4.
    Yi L; Zhou X; Li T; Liu P; Hai L; Tong L; Ma H; Tao Z; Xie Y; Zhang C; Yu S; Yang X
    J Exp Clin Cancer Res; 2019 Aug; 38(1):339. PubMed ID: 31382985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits.
    Zhao X; Zheng F; Li Y; Hao J; Tang Z; Tian C; Yang Q; Zhu T; Diao C; Zhang C; Chen M; Hu S; Guo P; Zhang L; Liao Y; Yu W; Chen M; Zou L; Guo W; Deng W
    Redox Biol; 2019 Jan; 20():427-441. PubMed ID: 30419422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of musashi1 increases malignancy of hepatocellular carcinoma via the Wnt/β-catenin signaling pathway and predicts a poor prognosis.
    Liu Q; Zhou C; Zhang B
    BMC Gastroenterol; 2019 Dec; 19(1):230. PubMed ID: 31888604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of MAGE-A9 contributes to stemness and malignancy of human hepatocellular carcinoma.
    Wei Y; Wang Y; Gong J; Rao L; Wu Z; Nie T; Shi D; Zhang L
    Int J Oncol; 2018 Jan; 52(1):219-230. PubMed ID: 29138811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ELK3 promotes the migration and invasion of liver cancer stem cells by targeting HIF-1α.
    Lee JH; Hur W; Hong SW; Kim JH; Kim SM; Lee EB; Yoon SK
    Oncol Rep; 2017 Feb; 37(2):813-822. PubMed ID: 27959451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
    Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
    J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.